Investing Profile

Adam Koppel

InvestorVC

Managing Director at Bain Capital Ventures

Your Intro Paths to Adam Koppel

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Adam is a member of

The Wharton School Network

814 CONNECTIONS

Mckinsey & Company Network

716 CONNECTIONS

Bain Capital Network

332 CONNECTIONS

Bain Capital Ventures Network

129 CONNECTIONS

Biogen Network

23 CONNECTIONS

Find Adam Koppel on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Adam Koppel is on these Sector & Stage Rankings

Adam Koppel's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Areteia Therapeutics	Series AFeb 2024$75M Series AJul 2022$350M	$430M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Paul Berns (ARCH Venture Partners)
Solid Biosciences	Post Ipo EquityJan 2024$110M Post Ipo EquitySep 2022$75M Series CMar 2017$50M	$230M
Co-investors: Luis Valdich (SoftBank Capital), Rajeev Shah (RA Capital Management)
Synapticure	SeedFeb 2022$6M	$41M
Co-investors: Adam Seabrook (B Capital Group), Ben Robbins (GV (Google Ventures)), Krishna Yeshwant (GV (Google Ventures)), Joe Kraus (GV (Google Ventures)), Ron Conway (Angel Investors LP Funds), Ben Silbermann (Pinterest), Ronald Conway Sr. (NewCo), David Hodgson (General Atlantic), Jeff Huber (Triatomic Capital)
ViaCyte	Series DNov 2018$80M	$140M
Co-investors: Heath Lukatch (Novo Holdings), Asish Xavier (Johnson & Johnson Innovation)
Cerevel Therapeutics	Private EquityOct 2018$350M	$350M
Co-investors: Chris Gordon (Bain Capital)
Aptinyx	Series BDec 2017$70M	$140M
Co-investors: James N. Topper (Xelas Consulting LLC), Liam Ratcliffe (New Leaf Venture Partners)
InflaRx	Series DOct 2017$55M	$55M
PTC Therapeutics	Private EquityMar 2013$60M	$130M
Co-investors: Andrew Schwab (5am Ventures), Rich Aldrich (Unknown Ventures)

Adam Koppel's Experience

Associate Principal Mckinsey & CompanyPresent

Managing Director Bain CapitalPresent

Managing Director Brookside CapitalPresent

EVP, Corporate Development & Strategy BiogenPresent

Managing Director Bain Capital VenturesPresent

Adam Koppel's Education

University of Pennsylvania School of Medicine MD PhD, Medicine; Neuroscience

University of Pennsylvania School of Medicine MD, PhD Medicine; Neuroscience

The Wharton School MBA Finance, Healthcare

Investors who invest with Adam Koppel

Scouts & Angels Affiliated With Adam Koppel